Toll-like receptors: Role in inflammation and therapeutic potential

BioFactors

Volumn 40, Issue 3, 2014, Pages 284-294

  Kay, Emma ^a   Scotland, Ramona S ^a   Whiteford, James R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

DAMP; Inflammation; Leukocyte; PAMP; Toll like receptor

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; COMPLEMENT COMPONENT C5A; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 8; L SELECTIN; LEUKOTRIENE B4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; OXIDIZED LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; ANTIINFLAMMATORY AGENT; AUTACOID;

CELL MIGRATION; CYTOKINE RELEASE; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MONOCYTE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SECRETORY GRANULE; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR ENDOTHELIUM; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE MARROW; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BONE MARROW; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MONOCYTES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84902548704     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1156     Document Type: Review

References (91)

1. Murphy, K., Travers, P., and Walport, M. (2008) Janeway's Immunobiology, 7th edn. Garland Science, New York.
2. Soehnlein, O. and Lindbom, L. (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10, 427-439.
3. Ziegler-Heitbrock, L., Ancuta, P., Crowe, S., Dalod, M., Grau, V., et al. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116, e74-e80.
4. Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., et al. (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317, 666-670.
5. Faurschou, M. and Borregaard, N. (2003) Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5, 1317-1327.
6. Phillipson, M. and Kubes, P. (2011) The neutrophil in vascular inflammation. Nat. Med. 17, 1381-1390.
7. Kolaczkowska, E. and Kubes, P. (2013) Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159-175.
8. Shi, C. and Pamer, E. G. (2011) Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11, 762-774.
9. Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., et al. (2010) Development of monocytes, macrophages, and dendritic cells. Science 327, 656-661.
10. Ley, K., Laudanna, C., Cybulsky, M. I., and Nourshargh, S. (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689.
11. Nourshargh, S., Hordijk, P. L., and Sixt, M. (2010) Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat. Rev. Mol. Cell Biol. 11, 366-378.
12. Furze, R. C. and Rankin, S. M. (2008) Neutrophil mobilization and clearance in the bone marrow. Immunology 125, 281-288.
13. Martin, C., Burdon, P. C., Bridger, G., Gutierrez-Ramos, J. C., Williams, T. J., et al. (2003) Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 19, 583-593.
14. Serbina, N. V. and Pamer, E. G. (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7, 311-317.
15. Shi, C., Jia, T., Mendez-Ferrer, S., Hohl, T. M., Serbina, N. V., et al. (2011) Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 34, 590-601.
16. Wang, Y., Cui, L., Gonsiorek, W., Min, S. H., Anilkumar, G., et al. (2009) CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis. J. Inflamm. (Lond.) 6, 32.
17. Tsou, C. L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A. M., et al. (2007) Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117, 902-909.
18. Swirski, F. K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., et al. (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612-616.
19. Medzhitov, R. and Janeway, C. (2000) The Toll receptor family and microbial recognition. Trends Microbiol. 8, 452-456.
20. Medzhitov, R. (2009) Approaching the asymptote: 20 years later. Immunity 30, 766-775.
21. Kawai, T. and Akira, S. (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384.
22. Akira, S. and Takeda, K. (2004) Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511.
23. Broz, P. and Monack, D. M. (2013) Newly described pattern recognition receptors team up against intracellular pathogens. Nat. Rev. Immunol. 13, 551-565.
24. Takeda, K., Kaisho, T., and Akira, S. (2003) Toll-like receptors. Annu. Rev. Immunol. 21, 335-376.
25. Bauer, E. M., Shapiro, R., Billiar, T. R., and Bauer, P. M. (2013) High mobility group Box 1 inhibits human pulmonary artery endothelial cell migration via a Toll-like receptor 4- and interferon response factor 3-dependent mechanism(s). J. Biol. Chem. 288, 1365-1373.
26. Akira, S., Uematsu, S., and Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-801.
27. Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., et al. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11, 155-161.
28. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., et al. (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782.
29. Lee, C. C., Avalos, A. M., and Ploegh, H. L. (2012) Accessory molecules for Toll-like receptors and their function. Nat. Rev. Immunol. 12, 168-179.
30. Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., et al. (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531-4537.
31. Sabroe, I., Jones, E. C., Usher, L. R., Whyte, M. K., and Dower, S. K. (2002) Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J. Immunol. 168, 4701-4710.
32. Jiang, W., Sun, R., Wei, H., and Tian, Z. (2005) Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. Proc. Natl. Acad. Sci. USA 102, 17077-17082.
33. Thorley, A. J., Grandolfo, D., Lim, E., Goldstraw, P., Young, A., et al. (2011) Innate immune responses to bacterial ligands in the peripheral human lung-role of alveolar epithelial TLR expression and signalling. PLoS One 6, e21827.
34. Faure, E., Equils, O., Sieling, P. A., Thomas, L., Zhang, F. X., et al. (2000) Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275, 11058-11063.
35. Zarember, K. A. and Godowski, P. J. (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168, 554-561.
36. Hornef, M. W., Frisan, T., Vandewalle, A., Normark, S., and Richter-Dahlfors, A. (2002) Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med. 195, 559-570.
37. Guillot, L., Medjane, S., Le-Barillec, K., Balloy, V., Danel, C., et al. (2004) Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J. Biol. Chem. 279, 2712-2718.
38. Schmausser, B., Andrulis, M., Endrich, S., Lee, S. K., Josenhans, C., et al. (2004) Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin. Exp. Immunol. 136, 521-526.
39. Palazzo, M., Balsari, A., Rossini, A., Selleri, S., Calcaterra, C., et al. (2007) Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion. J. Immunol. 178, 4296-4303.
40. John, G., Yildirim, A. O., Rubin, B. K., Gruenert, D. C., and Henke, M. O. (2010) TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells. Am. J. Respir. Cell Mol. Biol. 42, 424-431.
41. Chen, J., John, R., Richardson, J. A., Shelton, J. M., Zhou, X. J., et al. (2011) Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int. 79, 288-299.
42. Sawa, Y., Ueki, T., Hata, M., Iwasawa, K., Tsuruga, E., et al. (2008) LPS-induced IL-6, IL-8, VCAM-1, and ICAM-1 expression in human lymphatic endothelium. J. Histochem. Cytochem. 56, 97-109.
43. Ritter, M., Mennerich, D., Weith, A., and Seither, P. (2005) Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response. J. Inflamm. (Lond.) 2, 16.
44. Stridh, L., Smith, P. L., Naylor, A. S., Wang, X., and Mallard, C. (2011) Regulation of toll-like receptor 1 and -2 in neonatal mice brains after hypoxia-ischemia. J. Neuroinflammation 8, 45.
45. Visvanathan, K., Skinner, N. A., Thompson, A. J., Riordan, S. M., Sozzi, V., et al. (2007) Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45, 102-110.
46. Mempel, M., Voelcker, V., Kollisch, G., Plank, C., Rad, R., et al. (2003) Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J. Investig. Dermatol. 121, 1389-1396.
47. Wang, Y., Zhang, M. X., Meng, X., Liu, F. Q., Yu, G. S., et al. (2011) Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 300, H1743-H1752.
48. Lu, Z., Li, Y., Jin, J., Zhang, X., Lopes-Virella, M. F., et al. (2012) Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6. Arterioscler. Thromb. Vasc. Biol. 32, 1696-1706.
49. Erridge, C., Burdess, A., Jackson, A. J., Murray, C., Riggio, M., et al. (2008) Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma. Eur. J. Clin. Investig. 38, 713-720.
50. Dunzendorfer, S., Lee, H. K., Soldau, K., and Tobias, P. S. (2004) Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J. 18, 1117-1119.
51. Mullick, A. E., Soldau, K., Kiosses, W. B., Bell, T. A., Tobias, P. S., et al. (2008) Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J. Exp. Med. 205, 373-383.
52. Dunzendorfer, S., Lee, H. K., and Tobias, P. S. (2004) Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity. Circ. Res. 95, 684-691.
53. Khandoga, A. G., Khandoga, A., Anders, H. J., and Krombach, F. (2009) Postischemic vascular permeability requires both TLR-2 and TLR-4, but only TLR-2 mediates the transendothelial migration of leukocytes. Shock 31, 592-598.
54. Harrington, L. S., Belcher, E., Moreno, L., Carrier, M. J., and Mitchell, J. A. (2007) Homeostatic role of Toll-like receptor 4 in the endothelium and heart. J. Cardiovasc. Pharmacol. Ther. 12, 322-326.
55. Andonegui, G., Bonder, C. S., Green, F., Mullaly, S. C., Zbytnuik, L., et al. (2003) Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J. Clin. Invest. 111, 1011-1020.
56. Gatheral, T., Reed, D. M., Moreno, L., Gough, P. J., Votta, B. J., et al. (2012) A key role for the endothelium in NOD1 mediated vascular inflammation: comparison to TLR4 responses. PLoS One 7, e42386.
57. Cook, D. N., Pisetsky, D. S., and Schwartz, D. A. (2004) Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5, 975-979.
58. Kim, S. Y., Choi, Y. J., Joung, S. M., Lee, B. H., Jung, Y. S., et al. (2010) Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor. Immunology 129, 516-524.
59. Ishikawa, Y., Satoh, M., Itoh, T., Minami, Y., Takahashi, Y., and Akamura, M. (2008) Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction. Clin. Sci. (Lond.) 115, 133-140.
60. Kashiwagi, M., Imanishi, T., Ozaki, Y., Satogami, K., Masuno, T., et al. (2012) Differential expression of Toll-like receptor 4 and human monocyte subsets in acute myocardial infarction. Atherosclerosis 221, 249-253.
61. Ashida, K., Miyazaki, K., Takayama, E., Tsujimoto, H., Ayaori, M., et al. (2005) Characterization of the expression of TLR2 (toll-like receptor 2) and TLR4 on circulating monocytes in coronary artery disease. J. Atheroscler. Thromb. 12, 53-60.
62. Hadley, J. S., Wang, J. E., Michaels, L. C., Dempsey, C. M., Foster, S. J., et al. (2007) Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass. Shock 27, 466-473.
63. Härter, L., Mica, L., Stocker, R., Trentz, O., and Keel, M. (2004) Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 22, 403-409.
64. Chang, J. H., Hampartzoumian, T., Everett, B., Lloyd, A., McCluskey, P. J., et al. (2007) Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis. Invest. Ophthalmol. Vis. Sci. 48, 1711-1717.
65. Wolfs, T. G., Buurman, W. A., van Schadewijk, A., de Vries, B., Daemen, M. A., et al. (2002) In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J. Immunol. 168, 1286-1293.
66. Kruger, B., Krick, S., Dhillon, N., Lerner, S. M., Ames, S., et al. (2009) Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl. Acad. Sci. USA 106, 3390-3395.
67. Cario, E., Brown, D., McKee, M., Lynch-Devaney, K., Gerken, G., et al. (2002) Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am. J. Pathol. 160, 165-173.
68. Ridnour, L. A., Cheng, R. Y., Switzer, C. H., Heinecke, J. L., Ambs, S., et al. (2013) Molecular pathways: toll-like receptors in the tumor microenvironment-poor prognosis or new therapeutic opportunity. Clin. Cancer Res. 19, 1340-1346.
69. Yang, H. Z., Cui, B., Liu, H. Z., Mi, S., Yan, J., et al. (2009) Blocking TLR2 activity attenuates pulmonary metastases of tumor. PLoS One 4, e6520.
70. Higashimori, M., Tatro, J. B., Moore, K. J., Mendelsohn, M. E., Galper, J. B., et al. (2011) Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31, 50-57.
71. Mullick, A. E., Tobias, P. S., and Curtiss, L. K. (2005) Modulation of atherosclerosis in mice by Toll-like receptor 2. J. Clin. Invest. 115, 3149-3156.
72. Pryshchep, O., Ma-Krupa, W., Younge, B. R., Goronzy, J. J., and Weyand, C. M. (2008) Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation 118, 1276-1284.
73. Arslan, F., Keogh, B., McGuirk, P., and Parker, A. E. (2010) TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm. 2010, 704202.
74. Rusai, K., Sollinger, D., Baumann, M., Wagner, B., Strobl, M., et al. (2010) Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr. Nephrol. 25, 853-860.
75. Zhai, Y., Shen, X. D., O'Connell, R., Gao, F., Lassman, C., et al. (2004) Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173, 7115-7119.
76. Hyakkoku, K., Hamanaka, J., Tsuruma, K., Shimazawa, M., Tanaka, H., et al. (2010) Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171, 258-267.
77. Arslan, F., Smeets, M. B., O'Neill, L. A., Keogh, B., McGuirk, P., et al. (2010) Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 121, 80-90.
78. Victoni, T., Coelho, F. R., Soares, A. L., de Freitas, A., Secher, T., et al. (2010) Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signaling pathway. Med. Microbiol. Immunol. 199, 35-42.
79. Ohkuni, T., Kojima, T., Ogasawara, N., Masaki, T., Fuchimoto, J., et al. (2011) Poly(I:C) reduces expression of JAM-A and induces secretion of IL-8 and TNF-alpha via distinct NF-kappaB pathways in human nasal epithelial cells. Toxicol. Appl. Pharmacol. 250, 29-38.
80. Chun, J. and Prince, A. (2009) TLR2-induced calpain cleavage of epithelial junctional proteins facilitates leukocyte transmigration. Cell Host Microbe 5, 47-58.
81. Hennessy, E. J., Parker, A. E., and O'Neill, L. A. (2010) Targeting Toll-like receptors: emerging therapeutics? Nat. Rev. Drug Discov. 9, 293-307.
82. Connolly, D. J. and O'Neill, L. A. (2012) New developments in Toll-like receptor targeted therapeutics. Curr. Opin. Pharmacol. 12, 510-518.
83. Shirey, K. A., Lai, W., Scott, A. J., Lipsky, M., Mistry, P., et al. (2013) The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497, 498-502.
84. Ehrentraut, S., Lohner, R., Schwederski, M., Ehrentraut, H., Boehm, O., et al. (2011) In vivo Toll-like receptor 4 antagonism restores cardiac function during endotoxemia. Shock 36, 613-620.
85. Ehrentraut, H., Weber, C., Ehrentraut, S., Schwederski, M., Boehm, O., et al. (2011) The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy. Eur. J. Heart Fail. 13, 602-610.
86. Liu, M., Gu, M., Xu, D., Lv, Q., Zhang, W., et al. (2010) Protective effects of Toll-like receptor 4 inhibitor eritoran on renal ischemia-reperfusion injury. Transplant. Proc. 42, 1539-1544.
87. Tidswell, M., Tillis, W., Larosa, S. P., Lynn, M., Wittek, A. E., et al. (2010) Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis. Crit. Care Med. 38, 72-83.
88. Opal, S. M., Laterre, P. F., Francois, B., LaRosa, S. P., Angus, D. C., et al. (2013) Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA 309, 1154-1162.
89. Reilly, M., Miller, R. M., Thomson, M. H., Patris, V., Ryle, P., et al. (2013) Randomized, double-blind, placebo-controlled, dose-escalating phase i, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody. Clin. Pharmacol. Ther. 94, 593-600.
90. Farrar, C. A., Keogh, B., McCormack, W., O'Shaughnessy, A., Parker, A., et al. (2012) Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. FASEB J. 26, 799-807.
91. Arslan, F., Houtgraaf, J. H., Keogh, B., Kazemi, K., de Jong, R., et al. (2012) Treatment with OPN-305, a humanized anti-toll-like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs. Circ. Cardiovasc. Interv. 5, 279-287.